In agreement with the increased tubular expression of GSK3β in patients with progressive CKD, TGF-β1 treatment induced the TEC expression of GSK3β in a dose and time-dependent fashion (Fig. 2A, B). This evidence concerns the gene TGFB1 and chronic kidney disease.